This study has demonstrated that low expression of calpain-2 and high expression of calpastatin determined in diagnostic core biopsy samples is significantly associated with adverse breast cancer-specific survival in non-inflammatory large but operable primary breast cancer. The gene discussed is CAST; the disease is breast carcinoma.